Reviews - 1mry mentioned but not cited (2)
- Substrate and docking interactions in serine/threonine protein kinases. Goldsmith EJ, Akella R, Min X, Zhou T, Humphreys JM. Chem. Rev. 107 5065-5081 (2007)
- Computer-Aided Identification of Kinase-Targeted Small Molecules for Cancer: A Review on AKT Protein. Primavera E, Palazzotti D, Barreca ML, Astolfi A. Pharmaceuticals (Basel) 16 993 (2023)
Articles - 1mry mentioned but not cited (5)
- Conformational changes in redox pairs of protein structures. Fan SW, George RA, Haworth NL, Feng LL, Liu JY, Wouters MA. Protein Sci. 18 1745-1765 (2009)
- Computational insights into the inhibitory mechanism of human AKT1 by an orally active inhibitor, MK-2206. Rehan M, Beg MA, Parveen S, Damanhouri GA, Zaher GF. PLoS ONE 9 e109705 (2014)
- Structural bases of PAS domain-regulated kinase (PASK) activation in the absence of activation loop phosphorylation. Kikani CK, Antonysamy SA, Bonanno JB, Romero R, Zhang FF, Russell M, Gheyi T, Iizuka M, Emtage S, Sauder JM, Turk BE, Burley SK, Rutter J. J. Biol. Chem. 285 41034-41043 (2010)
- Cellular model system to dissect the isoform-selectivity of Akt inhibitors. Quambusch L, Depta L, Landel I, Lubeck M, Kirschner T, Nabert J, Uhlenbrock N, Weisner J, Kostka M, Levy LM, Schultz-Fademrecht C, Glanemann F, Althoff K, Müller MP, Siveke JT, Rauh D. Nat Commun 12 5297 (2021)
- ProSelection: A Novel Algorithm to Select Proper Protein Structure Subsets for in Silico Target Identification and Drug Discovery Research. Wang N, Wang L, Xie XQ. J Chem Inf Model 57 2686-2698 (2017)
Reviews citing this publication (20)
- Regulation of protein kinases; controlling activity through activation segment conformation. Nolen B, Taylor S, Ghosh G. Mol. Cell 15 661-675 (2004)
- Redox regulation of protein kinases. Corcoran A, Cotter TG. FEBS J. 280 1944-1965 (2013)
- AKT crystal structure and AKT-specific inhibitors. Kumar CC, Madison V. Oncogene 24 7493-7501 (2005)
- Redox homeostasis: the linchpin in stem cell self-renewal and differentiation. Wang K, Zhang T, Dong Q, Nice EC, Huang C, Wei Y. Cell Death Dis 4 e537 (2013)
- PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle. Dong LQ, Liu F. Am. J. Physiol. Endocrinol. Metab. 289 E187-96 (2005)
- The redox regulation of PI 3-kinase-dependent signaling. Leslie NR. Antioxid. Redox Signal. 8 1765-1774 (2006)
- Redox regulation of epidermal growth factor receptor signaling through cysteine oxidation. Truong TH, Carroll KS. Biochemistry 51 9954-9965 (2012)
- Forkhead box o as a sensor, mediator, and regulator of redox signaling. de Keizer PL, Burgering BM, Dansen TB. Antioxid. Redox Signal. 14 1093-1106 (2011)
- Redox regulation of protein kinases. Truong TH, Carroll KS. Crit. Rev. Biochem. Mol. Biol. 48 332-356 (2013)
- Lining the pockets of kinases and phosphatases. Gold MG, Barford D, Komander D. Curr. Opin. Struct. Biol. 16 693-701 (2006)
- Redox features of the cell: a gender perspective. Malorni W, Campesi I, Straface E, Vella S, Franconi F. Antioxid. Redox Signal. 9 1779-1801 (2007)
- Integrating opposing signals toward Forkhead box O. van den Berg MC, Burgering BM. Antioxid. Redox Signal. 14 607-621 (2011)
- The Hallmarks of Cancer from a Redox Perspective. Hornsveld M, Dansen TB. Antioxid. Redox Signal. 25 300-325 (2016)
- Integration of phosphoproteomic, chemical, and biological strategies for the functional analysis of targeted protein phosphorylation. Guo M, Huang BX. Proteomics 13 424-437 (2013)
- Redox regulation of cancer metastasis: molecular signaling and therapeutic opportunities. Yang W, Zou L, Huang C, Lei Y. Drug Dev. Res. 75 331-341 (2014)
- Protein cooperation: from neurons to networks. Volonté C, D'Ambrosi N, Amadio S. Prog. Neurobiol. 86 61-71 (2008)
- Redox Homeostasis in Pancreatic β-Cells: From Development to Failure. Benáková Š, Holendová B, Plecitá-Hlavatá L. Antioxidants (Basel) 10 526 (2021)
- Redox regulation of the insulin signalling pathway. Lennicke C, Cochemé HM. Redox Biol 42 101964 (2021)
- The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance. Weng MS, Chang JH, Hung WY, Yang YC, Chien MH. J. Exp. Clin. Cancer Res. 37 61 (2018)
- Serum and glucocorticoid-regulated kinase 1: Structure, biological functions, and its inhibitors. Jang H, Park Y, Jang J. Front Pharmacol 13 1036844 (2022)
Articles citing this publication (54)
- mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. Hresko RC, Mueckler M. J. Biol. Chem. 280 40406-40416 (2005)
- PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Brognard J, Sierecki E, Gao T, Newton AC. Mol. Cell 25 917-931 (2007)
- Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo. Calleja V, Alcor D, Laguerre M, Park J, Vojnovic B, Hemmings BA, Downward J, Parker PJ, Larijani B. PLoS Biol. 5 e95 (2007)
- Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition. Wu WI, Voegtli WC, Sturgis HL, Dizon FP, Vigers GP, Brandhuber BJ. PLoS ONE 5 e12913 (2010)
- A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles. Wang C, Weerapana E, Blewett MM, Cravatt BF. Nat. Methods 11 79-85 (2014)
- PKC maturation is promoted by nucleotide pocket occupation independently of intrinsic kinase activity. Cameron AJ, Escribano C, Saurin AT, Kostelecky B, Parker PJ. Nat. Struct. Mol. Biol. 16 624-630 (2009)
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Li CW, Lim SO, Xia W, Lee HH, Chan LC, Kuo CW, Khoo KH, Chang SS, Cha JH, Kim T, Hsu JL, Wu Y, Hsu JM, Yamaguchi H, Ding Q, Wang Y, Yao J, Lee CC, Wu HJ, Sahin AA, Allison JP, Yu D, Hortobagyi GN, Hung MC. Nat Commun 7 12632 (2016)
- 17Beta-estradiol protects against oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. Urata Y, Ihara Y, Murata H, Goto S, Koji T, Yodoi J, Inoue S, Kondo T. J. Biol. Chem. 281 13092-13102 (2006)
- Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1. Hindie V, Stroba A, Zhang H, Lopez-Garcia LA, Idrissova L, Zeuzem S, Hirschberg D, Schaeffer F, Jørgensen TJ, Engel M, Alzari PM, Biondi RM. Nat. Chem. Biol. 5 758-764 (2009)
- Allosteric activation of the protein kinase PDK1 with low molecular weight compounds. Engel M, Hindie V, Lopez-Garcia LA, Stroba A, Schaeffer F, Adrian I, Imig J, Idrissova L, Nastainczyk W, Zeuzem S, Alzari PM, Hartmann RW, Piiper A, Biondi RM. EMBO J. 25 5469-5480 (2006)
- Downregulation of catalase by reactive oxygen species via PI 3 kinase/Akt signaling in mesangial cells. Venkatesan B, Mahimainathan L, Das F, Ghosh-Choudhury N, Ghosh Choudhury G. J. Cell. Physiol. 211 457-467 (2007)
- Potential role of glutathione in evolution of thiol-based redox signaling sites in proteins. Mohanasundaram KA, Haworth NL, Grover MP, Crowley TM, Goscinski A, Wouters MA. Front Pharmacol 6 1 (2015)
- Structural basis for the regulation of protein kinase A by activation loop phosphorylation. Steichen JM, Kuchinskas M, Keshwani MM, Yang J, Adams JA, Taylor SS. J. Biol. Chem. 287 14672-14680 (2012)
- Akt Cys-310-targeted inhibition by hydroxylated benzene derivatives is tightly linked to their immunosuppressive effects. Lee JY, Lee YG, Lee J, Yang KJ, Kim AR, Kim JY, Won MH, Park J, Yoo BC, Kim S, Cho WJ, Cho JY. J. Biol. Chem. 285 9932-9948 (2010)
- Global consequences of activation loop phosphorylation on protein kinase A. Steichen JM, Iyer GH, Li S, Saldanha SA, Deal MS, Woods VL, Taylor SS. J. Biol. Chem. 285 3825-3832 (2010)
- Interdomain conformational changes in Akt activation revealed by chemical cross-linking and tandem mass spectrometry. Huang BX, Kim HY. Mol. Cell Proteomics 5 1045-1053 (2006)
- The structure of MSK1 reveals a novel autoinhibitory conformation for a dual kinase protein. Smith KJ, Carter PS, Bridges A, Horrocks P, Lewis C, Pettman G, Clarke A, Brown M, Hughes J, Wilkinson M, Bax B, Reith A. Structure 12 1067-1077 (2004)
- 3-D structure and dynamics of protein kinase B-new mechanism for the allosteric regulation of an AGC kinase. Calleja V, Laguerre M, Larijani B. J Chem Biol 2 11-25 (2009)
- Glutaredoxin mediates Akt and eNOS activation by flow in a glutathione reductase-dependent manner. Wang J, Pan S, Berk BC. Arterioscler. Thromb. Vasc. Biol. 27 1283-1288 (2007)
- InterAKTions with FKBPs--mutational and pharmacological exploration. Fabian AK, März A, Neimanis S, Biondi RM, Kozany C, Hausch F. PLoS ONE 8 e57508 (2013)
- Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells. Hövelmann S, Beckers TL, Schmidt M. Br. J. Cancer 90 2370-2377 (2004)
- Redox modification of Akt mediated by the dopaminergic neurotoxin MPTP, in mouse midbrain, leads to down-regulation of pAkt. Durgadoss L, Nidadavolu P, Valli RK, Saeed U, Mishra M, Seth P, Ravindranath V. FASEB J. 26 1473-1483 (2012)
- Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors. Ikuta M, Kornienko M, Byrne N, Reid JC, Mizuarai S, Kotani H, Munshi SK. Protein Sci. 16 2626-2635 (2007)
- Crystal structure of the kinase domain of serum and glucocorticoid-regulated kinase 1 in complex with AMP PNP. Zhao B, Lehr R, Smallwood AM, Ho TF, Maley K, Randall T, Head MS, Koretke KK, Schnackenberg CG. Protein Sci. 16 2761-2769 (2007)
- Differential activation of CREB by Akt1 and Akt2. Kato S, Ding J, Du K. Biochem. Biophys. Res. Commun. 354 1061-1066 (2007)
- Heterotetrameric sarcosine oxidase: structure of a diflavin metalloenzyme at 1.85 A resolution. Chen ZW, Hassan-Abdulah A, Zhao G, Jorns MS, Mathews FS. J. Mol. Biol. 360 1000-1018 (2006)
- Homo-oligomerization and activation of AMP-activated protein kinase are mediated by the kinase domain alphaG-helix. Scholz R, Suter M, Weimann T, Polge C, Konarev PV, Thali RF, Tuerk RD, Viollet B, Wallimann T, Schlattner U, Neumann D. J. Biol. Chem. 284 27425-27437 (2009)
- 4-benzimidazolyl-3-phenylbutanoic acids as novel PIF-pocket-targeting allosteric inhibitors of protein kinase PKCζ. Fröhner W, Lopez-Garcia LA, Neimanis S, Weber N, Navratil J, Maurer F, Stroba A, Zhang H, Biondi RM, Engel M. J. Med. Chem. 54 6714-6723 (2011)
- Regulation of the interaction between protein kinase C-related protein kinase 2 (PRK2) and its upstream kinase, 3-phosphoinositide-dependent protein kinase 1 (PDK1). Dettori R, Sonzogni S, Meyer L, Lopez-Garcia LA, Morrice NA, Zeuzem S, Engel M, Piiper A, Neimanis S, Frödin M, Biondi RM. J. Biol. Chem. 284 30318-30327 (2009)
- Differential thiol oxidation of the signaling proteins Akt, PTEN or PP2A determines whether Akt phosphorylation is enhanced or inhibited by oxidative stress in C2C12 myotubes derived from skeletal muscle. Tan PL, Shavlakadze T, Grounds MD, Arthur PG. Int. J. Biochem. Cell Biol. 62 72-79 (2015)
- Extracellular adenosine triphosphate protects oxidative stress-induced increase of p21(WAF1/Cip1) and p27(Kip1) expression in primary cultured renal proximal tubule cells: role of PI3K and Akt signaling. Lee YJ, Lee JH, Han HJ. J. Cell. Physiol. 209 802-810 (2006)
- Allosteric regulation of PKCθ: understanding multistep phosphorylation and priming by ligands in AGC kinases. Seco J, Ferrer-Costa C, Campanera JM, Soliva R, Barril X. Proteins 80 269-280 (2012)
- Cigarette Smoke Disrupted Lung Endothelial Barrier Integrity and Increased Susceptibility to Acute Lung Injury via Histone Deacetylase 6. Borgas D, Chambers E, Newton J, Ko J, Rivera S, Rounds S, Lu Q. Am. J. Respir. Cell Mol. Biol. 54 683-696 (2016)
- Bioinformatics-based discovery and characterization of an AKT-selective inhibitor 9-chloro-2-methylellipticinium acetate (CMEP) in breast cancer cells. Zhang M, Fang X, Liu H, Guo R, Wu X, Li B, Zhu F, Ling Y, Griffith BN, Wang S, Yang D. Cancer Lett. 252 244-258 (2007)
- Inhibition of H2O2-induced cell death through FOXO1 modulation by EUK-172 in SK-N-MC cells. Gheysarzadeh A, Yazdanparast R. Eur. J. Pharmacol. 697 47-52 (2012)
- Nitric oxide activates intradomain disulfide bond formation in the kinase loop of Akt1/PKBα after burn injury. Lu XM, Tompkins RG, Fischman AJ. Int. J. Mol. Med. 31 740-750 (2013)
- Phenylalanine-Based Inactivator of AKT Kinase: Design, Synthesis, and Biological Evaluation. Nguyen T, Coover RA, Verghese J, Moran RG, Ellis KC. ACS Med Chem Lett 5 462-467 (2014)
- Solution structure of the oncogenic MIEN1 protein reveals a thioredoxin-like fold with a redox-active motif. Hsu CH, Shen TL, Chang CF, Chang YY, Huang LY. PLoS ONE 7 e52292 (2012)
- AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway-Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B. Xu J, Yu X, Martin TC, Bansal A, Cheung K, Lubin A, Stratikopoulos E, Cahuzac KM, Wang L, Xie L, Zhou R, Shen Y, Wu X, Yao S, Qiao R, Poulikakos PI, Chen X, Liu J, Jin J, Parsons R. Cancer Discov 11 3064-3089 (2021)
- Akt2 and p-Akt overexpression in oral cancer cells is due to a reduced rate of protein degradation. Archewa P, Pata S, Chotjumlong P, Supanchart C, Krisanaprakornkit S, Iamaroon A. J Investig Clin Dent 8 (2017)
- Conformational changes in Akt1 activation probed by amide hydrogen/deuterium exchange and nano-electrospray ionization mass spectrometry. Guo M, Huang BX, Kim HY. Rapid Commun. Mass Spectrom. 23 1885-1891 (2009)
- Fine-tuning AKT kinase activity through direct lysine methylation. Guo J, Wei W. Cell Cycle 18 917-922 (2019)
- Differential carbonylation of proteins in end-stage human fatty and nonfatty NASH. Shearn CT, Saba LM, Roede JR, Orlicky DJ, Shearn AH, Petersen DR. Free Radic. Biol. Med. 113 280-290 (2017)
- SILAM for quantitative proteomics of liver Akt1/PKBα after burn injury. Lu XM, Tompkins RG, Fischman AJ. Int. J. Mol. Med. 29 461-471 (2012)
- The Akt isoforms, their unique functions and potential as anticancer therapeutic targets. Santi SA, Douglas AC, Lee H. Biomol Concepts 1 389-401 (2010)
- Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses. Kadioglu O, Saeed M, Kuete V, Greten HJ, Efferth T. Front Pharmacol 9 355 (2018)
- Structural study of the catalytic domain of PKCzeta using infrared spectroscopy and two-dimensional infrared correlation spectroscopy. Sánchez-Bautista S, Kazaks A, Beaulande M, Torrecillas A, Corbalán-García S, Gómez-Fernández JC. FEBS J. 273 3273-3286 (2006)
- AKTs/PKBs: molecular characterization, tissue expression and transcriptional responses to insulin and/or wortmannin in yellow catfish Pelteobagrus fulvidraco. Zhuo MQ, Pan YX, Wu K, Xu YH, Zhang LH, Luo Z. Fish Physiol. Biochem. 43 719-730 (2017)
- Complexity of NAC Action as an Antidiabetic Agent: Opposing Effects of Oxidative and Reductive Stress on Insulin Secretion and Insulin Signaling. Argaev-Frenkel L, Rosenzweig T. Int J Mol Sci 23 2965 (2022)
- Global redox proteome and phosphoproteome analysis reveals redox switch in Akt. Su Z, Burchfield JG, Yang P, Humphrey SJ, Yang G, Francis D, Yasmin S, Shin SY, Norris DM, Kearney AL, Astore MA, Scavuzzo J, Fisher-Wellman KH, Wang QP, Parker BL, Neely GG, Vafaee F, Chiu J, Yeo R, Hogg PJ, Fazakerley DJ, Nguyen LK, Kuyucak S, James DE. Nat Commun 10 5486 (2019)
- Molecular docking appraisal of Dysphania ambrosioides phytochemicals as potential inhibitor of a key triple-negative breast cancer driver gene. Anifowose LO, Paimo OK, Adegboyega FN, Ogunyemi OM, Akano RO, Hammad SF, Ghazy MA. In Silico Pharmacol 11 15 (2023)
- Redox States of Protein Cysteines in Pathways of Protein Turnover and Cytoskeleton Dynamics Are Changed with Aging and Reversed by Slc7a11 Restoration in Mouse Lung Fibroblasts. Zheng Y, Merchant ML, Burke TJ, Ritzenthaler JD, Li M, Gaweda AE, Benz FW, Roman J, Watson WH. Oxid Med Cell Longev 2020 2468986 (2020)
- Structural basis of a redox-dependent conformational switch that regulates the stress kinase p38α. Pous J, Baginski B, Martin-Malpartida P, González L, Scarpa M, Aragon E, Ruiz L, Mees RA, Iglesias-Fernández J, Orozco M, Nebreda AR, Macias MJ. Nat Commun 14 7920 (2023)
- Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells. López-Grueso MJ, González R, Muntané J, Bárcena JA, Padilla CA. Antioxidants (Basel) 8 (2019)